Objectives:
Background

Description of the condition
Influenza occurs seasonally and in most cases causes an acute self-limiting respiratory infection, and febrile illness. It is sometimes accompanied with other symptoms such as myalgia, headache, malaise and fatigue. Even though the incidence of influenza in pregnant women is similar compared to non-pregnant women, they are at an increased risk of respiratory complications, hospital and intensive care admissions, especially in epidemic and pandemic years. 1, 2, 3, 4 The increase in risk is thought to be due to the immunologic and physiologic changes that occur in pregnancy. The immune system in pregnant women changes so that they can tolerate a genetically foreign foetus, with half of the genes coming from the father. These changes are not well understood and are thought to result in a shift from cell-mediated immunity towards humoral immunity. Combined with changes with increased heart rate, oxygen consumption and decreased lung capacity, it is thought to make pregnant women more susceptible to infectious diseases, including influenza. 5 These changes may also have an impact on the effectiveness of the influenza vaccine in preventing complications from infection. Pregnancy places women at even greater risk if they have a coexisting illness or risk factor, such as asthma or obesity.
Women in this group were shown to have poorer outcomes during the H1N1 influenza pandemic of 2009. 1 The effect of influenza on the foetus in mothers infected with influenza is not as clear, due to conflicting or incomplete outcomes from epidemiological studies. Overall the risk of transplacental transmission is thought to be low, despite case reports of in-utero infection confirmed with viral culture 6 . In times of pandemic it does appear that the risk of harm to the foetus of pregnant women rises. A retrospective cohort study during the H1N1 09 pandemic found that pregnant women infected with influenza had an increased risk of preterm delivery and perinatal mortality, when compared to non-infected pregnant Similar to pregnant women, children aged 0-6 months are more susceptible to complications from influenza if they have an underlying comorbidity, such as, heart, lung, neurological or neuromuscular conditions 9, 10 . For children under the age of 6 months it may be possible that influenza antibodies transferred by their mother may provide some protection for the first couple of months of life.
Description of the intervention
Influenza vaccination is the primary preventive measure to reduce complications from influenza.
Mutation of the virus from antigenic drift means that the make up of the vaccine may need to change on a yearly basis, or more frequently in the case of a pandemic strain. The accuracy of the match of the vaccine strains to the circulating strain has been shown to be important in the effectiveness of vaccine 
Why it is important to do this review
The decision to recommend a vaccine requires weighing the evidence of benefit against the risk of harm. In a Cochrane review "Vaccines for preventing influenza in healthy adults", Jefferson et al, noted that research on influenza vaccination had a high risk of bias 30 . No recent or underway systematic reviews were found in a search of JBI Library of Systematic Reviews, Cochrane Library, PubMed, Cinahl and Prospero. There are some thorough reviews and articles, but none have been done using published on this topic using systematic review methodology. 
Search strategy
The search strategy aims to find both published and unpublished studies. A three-step search strategy will be utilised in this review. An initial limited search of PUBMED and EMBASE will be undertaken followed by analysis of the text words contained in the title and abstract, and of the index terms used to describe article. A second search using all identified keywords and index terms will then be undertaken across all included databases. Thirdly, the reference list of all identified reports and articles will be searched for additional studies. Studies published in English will be considered for inclusion in this review. Studies published from the inception of each database will be considered for inclusion in this review.
The databases to be searched include:
PUBMED, EMBASE, SCOPUS and Web of Science
The search for unpublished studies will include: 
Assessment of methodological quality
Papers selected for retrieval will be assessed by two independent reviewers for methodological validity prior to inclusion in the review using standardised critical appraisal instruments from the Joanna Briggs
Institute Meta Analysis of Statistics Assessment and Review Instrument (JBI-MAStARI) (Appendix I).
Any disagreements that arise between the reviewers will be resolved through discussion, or with a third reviewer.
Data collection
Data will be extracted from papers included in the review using the standardised data extraction tool from JBI-MAStARI (Appendix II). The data extracted will include specific details about the interventions, populations, study methods and outcomes of significance to the review question and specific objectives.
Data synthesis
Quantitative data will, where possible be pooled in statistical meta-analysis using JBI-MAStARI. All results will be subject to double data entry. Effect sizes expressed as odds ratio (for categorical data) and weighted mean differences (for continuous data) and their 95% confidence intervals will be calculated for analysis. Heterogeneity will be assessed statistically using the standard Chi-square and also explored using subgroup analyses based on the different study designs included in this review.
Where statistical pooling is not possible the findings will be presented in narrative form including tables and figures to aid in data presentation where appropriate.
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